Evidence map›Paper›PMID 32799859›Full record

ArticleBMC medical ethics2020

Public trust and global biobank networks.

Lisa Dive, Christine Critchley, Margaret Otlowski, Paul Mason, Miriam Wiersma, Edwina Light, Cameron Stewart, Ian Kerridge, Wendy Lipworth

Abstract read
In one paragraph

Article in BMC medical ethics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Quantifying the impact of biobanks and cohort studies.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Trust and Support for Cancer Research Biobanks: Insights from Cancer Patients in Poland.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lisa DiveSydney Health Ethics, University of Sydney, Sydney, Australia. lisa.dive@sydney.edu.au.ORCID 0000-0001-6655-5138
Christine CritchleyDepartment of Psychological Sciences, School of Health Sciences, Swinburne University of Technology; and Centre for Law and Genetics, University of Tasmania, Hobart, Australia.
Margaret OtlowskiFaculty of Law, University of Tasmania, Hobart, Australia.
Paul MasonTaronga Institute of Science and Learning, Taronga Conservation Society, Mosman, Australia.
Miriam WiersmaSydney Health Ethics, University of Sydney, Sydney, Australia.
Edwina LightSydney Health Ethics, University of Sydney, Sydney, Australia.
Cameron StewartSydney Health Ethics, University of Sydney, Sydney, Australia.
Ian KerridgeSydney Health Ethics, University of Sydney, Sydney, Australia.
Wendy LipworthSydney Health Ethics, University of Sydney, Sydney, Australia.

Funding

National Health and Medical Research Council APP1083980
6 · The paper itself

Abstract

backgroundBiobanks provide an important foundation for genomic and personalised medicine. In order to enhance their scientific power and scope, they are increasingly becoming part of national or international networks. Public trust is essential in fostering public engagement, encouraging donation to, and facilitating public funding for biobanks. Globalisation and networking of biobanking may challenge this trust.

methodsWe report the results of an Australian study examining public attitudes to the networking and globalisation of biobanks. The study used quantitative and qualitative methods in conjunction with bioethical analysis in order to determine factors that may contribute to, and threaten, trust.

resultsOur results indicate a generally high level of trust in biobanks and in medical research more broadly. Key factors that can reduce perceived trustworthiness of biobanks are commercialisation and involvement in global networking.

conclusionsWe conclude that robust ethical oversight and governance standards can both promote trust in global biobanking and ensure that this trust is warranted.

Indexed as

Biological Specimen BanksBiomedical ResearchAustraliaHumansPublic OpinionTrustBiobanksCommercialisationGlobalisationTrust

Identifiers

PMID32799859
PMCPMC7429755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.